manbet体育网址我们定期科学是公认的顶级同行评议的科学期刊。
我们应用最高科学严谨工作并分享经验推进科学能造福社会。因此,我们的科学家和他们的作品经常发表在同行评议期刊。评审选择我们的出版物。
Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition by Judge et al. Nature Communications 2022
\r\nSynovial Inflammatory Pathways Characterize Anti-TNF-Responsive Rheumatoid Arthritis Patients by Wang et al. Arthritis & Rheumatology 2022
\r\nPathophysiologic and Pharmacologic Considerations to Improve the Design and Application of Antibody-Drug Conjugates by Boghaert et al. Cancer Research 2022
\r\nA data-driven and topological mapping approach for the a priori prediction of stable molecular crystalline hydrates by Hong et a. PNAS 2022
\r\nHigh-Throughput Intact Protein Analysis for Drug Discovery Using Infrared Matrix-Assisted Laser Desorption Electrospray Ionization Mass Spectrometry by Pu et al. Analytical Chemistry 2022
\r\nWater structure in glycerol: Spectroscopic and computer simulation investigation of hydrogen bonding and water clustering by Wu et al. Journal of Molecular Liquids 2022
\r\nAntiviral Drug Discovery for the Treatment of COVID-19 Infections by Ng et al. Viruses 2022
\r\nEvaluation of Quantitative Platforms for Single Target Mass Spectrometry Imaging by Bowman et al. Pharmaceuticals 2022
\r\nBotulinum Neurotoxin Type A Directly Affects Sebocytes and Modulates Oleic Acid-Induced Lipogenesis by Brami-Cherrier et al. Toxins 2022
\r\nRisk of Severe COVID-19 Outcomes Among Patients with Immune-Mediated Inflammatory Diseases or Malignancies: A Retrospective Analysis of Real-World Data in the United States by Yue et al. Advances in Therapy 2022
\r\nDetecting crystallinity in amorphous solid dispersions using dissolution testing: Considerations on properties of drug substance, drug product, and selection of dissolution media by Purohit et al. Journal of Pharmaceutical Sciences 2022
\r\nDesign of a Re-Dispersible High Drug Load Amorphous Formulation by Oberoi et al. Journal of Pharmaceutical Science
\r\nSystems genomics in age-related macular degeneration by Den Hollander et al. Experimental Eye Research
\r\nInterdisciplinary model-informed drug development for extending duration of elagolix treatment in patients with uterine fibroids by Beck et al. British Journal of Clinical Pharmacology
\r\nBTK-1: A Novel Positron Emission Tomography Tracer for Imaging Bruton’s Tyrosine Kinase by Skaddan et al. Molecular Imaging and Biology
\r\nIn vitro inflammatory and immune response to uncrosslinked hyaluronic
\r\n\r\n"}}" id="text-74aa32f3f3" class="cmp-text">
阿尔茨海默病的淀粉样蛋白假说:新疗法的新见解Karran et al。自然评论2022年药物发现
PAPP-ABP5复杂结构揭示了底物识别机制法官et al . 2022年自然通讯
滑膜炎症途径描述Anti-TNF-Responsive风湿性关节炎患者2022年王et al .关节炎和风湿病
病理生理和药理学考虑提高抗体药物的设计和应用共轭由Boghaert et al . 2022年癌症研究
数据驱动和拓扑映射方法的先验预测分子结晶水合物稳定通过香港等PNAS 2022
高通量药物发现完整的蛋白质分析使用红外Matrix-Assisted激光解吸附电喷雾电离质谱2022年聚氨酯等。分析化学
水在甘油结构:光谱和计算机模拟的调查氢键和水聚类2022年吴et al。《分子液体
抗病毒药物发现COVID-19感染的治疗Ng et al . 2022年病毒
针对单一目标质谱定量评价平台成像2022年鲍曼等。制药
肉毒神经毒素类型直接影响架构及和调节油的段脂肪生成2022年Brami-Cherrier et al .毒素
风险的严重COVID-19免疫介导的炎性疾病或恶性肿瘤患者的生存率:现实世界数据的回顾性分析在美国2022年曰等。治疗的进步
检测结晶度在非晶态固体分散体使用解散测试:考虑药物的物质属性,药物产品,和媒体选择解散由Purohit et al . 2022年制药科学杂志
y20胶粉的设计高药物负载非晶形成在Oberoi et al .制药科学杂志》上
系统基因组学在年龄相关性黄斑变性窝打浆机et al。实验研究
跨学科model-informed药物开发扩展的持续时间狗万正网地址elagolix治疗子宫肌瘤患者贝克等。英国临床药理学杂志》上
BTK-1:正电子发射断层扫描示踪成像布鲁顿的酪氨酸激酶Skaddan et al。分子成像和生物
Venetoclax increases intratumoral effector t cells and antitumor efficacy in combination with immune checkpoint blockade by Kohlhapp et al. Cancer Discovery, 2021 (IF 29.497)
\r\n\r\nHarnessing cerebrospinal fluid circulation for drug delivery to brain tissues by Naseri Kouzehgarani et al. Advanced Drug Delivery Reviews, 2021 (IF 13.3)
\r\n\r\nFoslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease by Rosenbraugh et al. Annals of Neurology, 2021 (IF 9.037)
\r\n\r\nHigh-Throughput Label-Free Biochemical Assays Using Infrared Matrix-Assisted Desorption Electrospray Ionization Mass Spectrometry by Pu et al. Analytical Chemistry, 2021 (IF 6.785)
\r\n\r\nOptimized Culture Conditions for Improved Growth and Functional Differentiation of Mouse and Human Colon Organoids by Wilson et al. Frontiers in Immunology, 2021 (IF 5.085)
\r\n\r\nCollecting antibodies and large molecule biomarkers in mouse interstitial brain fluid: a comparison of microdialysis and cerebral open flow microperfusion by Le Prieult et al. MAbs, 2021 (IF 4.634)
\r\n\r\nValidation of a quantitative systems pharmacology model of calcium homeostasis using elagolix Phase 3 clinical trial data in women with endometriosis by Stodtman et al. Clinical Translational Science, 2021 (IF 3.373)
\r\n\r\n"}}" id="text-f2fa89120d" class="cmp-text">Venetoclax增加瘤内效应t细胞和抗肿瘤功效结合免疫检查点封锁Kohlhapp et al .癌症发现,2021 (29.497)
利用脑脊液循环的药物输送到大脑组织由Naseri Kouzehgarani et al。先进的药物输送评论,2021 (13.3)
Foslevodopa /Foscarbidopa:一个新的皮下治疗帕金森病Rosenbraugh et al。神经病学年鉴,2021 (9.037)
高通量Label-Free生化检测,使用红外Matrix-Assisted解吸附电喷雾电离质谱分析由聚氨酯等。分析化学,2021 (6.785)
优化培养条件改进的生长和功能分化的老鼠和人类结肠癌瀑样2021年威尔逊et al .免疫学前沿,(5.085)
收集抗体和大型分子生物标志物在老鼠大脑间质流体:比较microdialysis和脑开放流microperfusion2021年Le Prieult et al . mab(如4.634)
验证的定量系统药理学的钙稳态模型使用elagolix在子宫内膜异位症的女性3期临床试验数据Stodtman et al。临床转化科学,2021 (3.373)
A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival by Turan et al. British Journal of Cancer, 2020 (IF 5.791)
\r\nEpitope and Fc-mediated cross-linking, but not high affinity, are critical for antitumor activity of CD137 agonist antibody with reduced liver toxicity by Ho et al. Molecular Cancer Therapeutics, 2020 (IF 5.615)
\r\nCoproporphyrin I Can Serve as an Endogenous Biomarker for OATP1B1 Inhibition: Assessment Using a Glecaprevir/Pibrentasvir Clinical Study by Kalluri et al. Clinical Translational Science, 2020 (IF 3.373)
\r\nMachine learning prediction of oncology drug targets based on protein and network properties by Dezso et al BMC Bioinformatics, 2020 (IF 3.242)
\r\nEvaluation of Tissue Stem Cell–Derived Human Intestinal Organoids, a Physiologically Relevant Model to Evaluate Cytochrome P450 Induction in Gut by Stresser et al. Drug Metabolism and Disposition, 2020 (IF 3.231)
\r\n\r\n"}}" id="text-1e759cac27" class="cmp-text">
选择性的抑制BD2 bromodomain打赌蛋白质的前列腺癌副检察官et al ., 2020 (42.779)
分数之间的平衡免疫刺激和抑制肿瘤免疫微环境识别介质和预测pan-cancer生存图兰et al。英国癌症杂志,2020 (5.791)
表位和Fc-mediated交联,但不是高亲和力,是抗肿瘤的关键活动CD137受体激动剂的抗体减少肝脏毒性何鸿燊et al .分子癌症疗法,2020 (5.615)
粪卟啉我可以作为一个OATP1B1抑制内源性生物标志物:使用Glecaprevir / Pibrentasvir临床研究评估Kalluri et al。临床转化科学,2020 (3.373)
机器学习的预测肿瘤药物靶点基于蛋白质和网络属性2020年Dezso et al BMC生物信息学,(如3.242)
评估组织的人类肠道干细胞瀑样,生理相关模型来评估在肠道细胞色素P450感应通过应激物et al .药物代谢和性格,2020 (3.231)
在药物发现中使用斑马鱼毒理学Cassar et al。化学毒理学研究,2019 (3.184)
Copyright © 2023 AbbVie Inc. North Chicago, Illinois, U.S.A.
\r\n"}}" id="text-fa25c81377" class="cmp-text">除非另有规定,所有产品名称出现在本网站商标或许可AbbVie Inc .旗下的子公司或分支机构。没有使用任何AbbVie商标,商号,或贸易服装在这个网站可能没有AbbVie Inc .的事先书面授权,除了确定公司的产品或服务。
版权©2023 AbbVie Inc .北芝加哥,伊利诺斯州,美国
您所要求的特定于产品的网站的互联网网站,面向一个特定的国家或国家的居民,如上所述。因此,网站可能包含药品信息在其他国家或地区不批准。如果你是一个国家的居民以外的站点,请返回AbbVie.com或联系你当地AbbVie下属获得适当的产品信息为您的居住国。的网站要求不得优化你的屏幕大小。你希望继续这个特定于产品的网站吗?